ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
개 백신 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.4%를 나타내 50억 5,000만 달러로 성장할 전망입니다. 예측기간의 성장은 반려동물 사육률 증가, 반려동물 주인의 건강 의식, 정부의 규제와 의무화, 반려동물의 인간화 증가, 개 질병의 유행에 기인합니다. 예측 기간의 주요 동향은 반려동물 보험 및 건강 관리 계획, 가용성 및 접근성, 맞춤형 백신 접종 프로토콜, 질병 패턴 변화, 새로운 백신 개발 등이 있습니다.
향후 5년간의 성장률 7.4%라고 하는 예측은 전회 예측으로부터 0.1%의 미감소를 반영하고 있습니다. 이러한 감소는 주로 미국과 기타 국가 간의 관세의 영향 때문입니다. 이탈리아의 동결건조(냉동건조) 장비에 대한 관세 상승은 미국 개 백신 제조업체의 설비 투자액을 인상하고 생산 능력 확대를 둔화시킬 수 있습니다. 또한 상호 관세와 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더 광범위하게 늘어날 것으로 보입니다.
애완견의 보급이 향후의 개 백신 시장 성장을 견인할 것으로 예측됩니다. 애완견은 가정에서 기르거나 길들인 반려동물로 정의됩니다. 개 백신은 강아지의 단계부터 성견이 될 때까지 시리즈에서 투여되는 주사입니다. 이 백신은 면역계를 자극하고, 개가 미생물에 맞서고, 질병을 피하고, 증상이 가벼워지도록 도와줍니다. 예를 들어 미국의 비영리업계 단체인 미국 반려동물 용품협회가 2021년부터 2022년에 걸쳐 실시한 '전미 반려동물 사육자 조사'에 따르면 미국에서는 70%의 가구가 반려동물을 길렀으며, 그 수는 9,050만 가구에 해당합니다. 이 중 개를 반려동물로 키운 가구는 6,900만 가구로, 다른 유형의 반려동물에 비해 가장 많았습니다. 따라서 애완견의 보급은 개 백신 시장 성장에 기여하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 개 백신 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 개 백신 시장 : 성장률 분석
세계의 개 백신 시장 실적 : 규모와 성장(2019-2024년)
세계의 개 백신 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 개 백신 : 전체 시장(TAM)
제6장 시장 세분화
세계의 개 백신 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
약독화 생백신
접합 백신
불활화 백신
서브 유닛 백신
톡소이드 백신
DNA 백신
재조합 백신
세계의 개 백신 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
피하
근육 내
비강 내
세계의 개 백신 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
6개월 미만
6개월 이상
세계의 개 백신 시장 : 약독화 생백신 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
개 파르보바이러스 백신
개 디스템퍼 백신
개 아데노바이러스 백신
세계의 개 백신 시장 : 접합 백신 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
개 렙토스피라 백신
개 볼데테라 백신
세계의 개 백신 시장 : 불활화 백신 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
개 파르보바이러스 백신
개 인플루엔자 백신
세계의 개 백신 시장 : 서브 유닛 백신 유형별, 2019-2024, 2024-2029F, 2034F
개 라임병 백신
개 파라인플루엔자 백신
세계의 개 백신 시장 : 톡소이드 백신 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
개 렙토스피라증 톡소이드 백신
세계의 개 백신 시장 : DNA 백신 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
개 흑색종 백신
세계의 개 백신 시장 : 재조합 백신 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
개 라임병 재조합 백신
개 볼데테라 재조합 백신
제7장 지역별/국가별 분석
세계의 개 백신 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 개 백신 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
개 백신 시장 : 경쟁 구도
개 백신 시장 : 기업 프로파일
Vetoquinol SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Boehringer Ingelheim GmbH : 개요, 제품 및 서비스, 전략 및 재무 분석
Ceva Sante Animale : 개요, 제품 및 서비스, 전략 및 재무 분석
Heska Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Virbac Animal Health Pvt. Ltd.
Elanco Animal Health Incorporated
Zoetis Inc.
CZ Vaccines
Indian Immunologicals Ltd.
Meiji Holdings Co. Ltd.
Bioveta AS
Phibro Animal Health Corporation
Hester Biosciences Limited
High Speed Digieal Processor Architecture Pvt. Ltd.
Dechra Pharmaceuticals PLC
Norbrook Inc.
Biogenesis Bago SA
Vaxxinova India Private Limited
Bimeda Animal Health Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
개 백신 시장(2029년) : 새로운 기회를 제공하는 국가
개 백신 시장(2029년) : 새로운 기회를 제공하는 부문
개 백신 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Dog vaccines constitute a series of administered injections, commencing during the puppy stage and extending into adulthood. These vaccines aim to introduce small amounts of a virus particle to trigger an immune response in the dog's body. This proactive measure enables the dog to mount an immune defense in the event of exposure to bacteria or viruses, thereby preventing illness.
Key categories of dog vaccines encompass attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines. Attenuated live vaccines involve creating a vaccine by reducing the virulence of a pathogen while maintaining its viability. Administration methods include subcutaneous, intramuscular, and intranasal routes, catering to dogs below 6 months and those above 6 months.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.
The dog vaccines market research report is one of a series of new reports from The Business Research Company that provides dog vaccines market statistics, including dog vaccines industry global market size, regional shares, competitors with an dog vaccines market share, detailed dog vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the dog vaccines industry. This dog vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The dog vaccines market size has grown strongly in recent years. It will grow from $3.61 billion in 2024 to $3.8 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to innovative vaccination protocols, zoonotic disease awareness, globalization and travel, educational campaigns, research and vaccine development, veterinary practice evolution.
The dog vaccines market size is expected to see strong growth in the next few years. It will grow to $5.05 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing pet adoption rates, health consciousness among pet owners, government regulations and mandates, rising humanization of pets, prevalence of canine diseases. Major trends in the forecast period include pet insurance and healthcare plans, availability and accessibility, customized vaccination protocols, changing disease patterns, development of novel vaccines.
The forecast of 7.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Higher tariffs on Italian lyophilization (freeze-drying) equipment will raise CapEx for U.S. canine-vaccine manufacturers, potentially slowing capacity expansions. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing adoption of pet dogs is anticipated to drive the growth of the dog vaccines market in the future. A pet dog is defined as a domesticated or tamed companion animal that lives in a household. Dog vaccines are injections administered in a series, beginning in the puppy stage and continuing into adulthood. These vaccines stimulate the immune system, helping dogs to confront microorganisms and either avoid illness or experience less severe symptoms. For example, according to the National Pet Owners Survey conducted by the American Pet Products Association for 2021-2022, a US-based non-profit industry association, 70% of households in the United States owned a pet, equating to 90.5 million homes. Among these, 69 million U.S. households had a dog as a pet, the highest number compared to other types of pets. Therefore, the rise in the adoption of pet dogs is contributing to the growth of the dog vaccines market.
The increasing prevalence of zoonotic diseases is projected to drive the growth of the dog vaccines market in the future. Zoonotic diseases, also referred to as zoonoses, are infectious diseases that can be transmitted naturally between animals and humans and vice versa. Dog vaccines are essential in preventing the transmission of zoonotic diseases from dogs to humans and play a significant role in public health initiatives aimed at controlling and managing zoonotic infections. For example, in February 2023, the Council on Foreign Relations (CFR), a US-based independent, nonpartisan think tank and publisher, reported that up to 75% of newly discovered or emerging infectious diseases (EIDs) and 60% of recognized infectious diseases have zoonotic origins. Globally, zoonoses result in 2.7 million human deaths and 2.5 billion instances of disease annually. Thus, the increasing prevalence of zoonotic diseases is fueling the growth of the dog vaccines market.
Technological advancements are emerging as a prominent trend in the dog vaccines market. Leading companies in the market are leveraging novel technologies for vaccine development. Merck Animal Health, a notable player, introduced Nobivac Intra-Trac Oral BbPi in September 2022. This oral vaccine, featuring mucosal protection and easy administration, represents a technological leap forward. It employs the innovative Immuno-Mist-R technology by Intervet, a Merck & Co subsidiary, significantly enhancing mucosal surface area contact. This technological progress in vaccine development contributes to the effectiveness and ease of administration in the dog vaccines market.
Major companies in the dog vaccines market are concentrating on innovative rabies vaccines to gain a competitive edge. The introduction of a three-dose rabies vaccine by Cadila Pharmaceuticals exemplifies this focus on innovation. Launched in April 2022, ThRabis is a recombinant nanoparticle-based rabies G protein vaccine, utilizing virus-like particle technology. The vaccine, generated from cloned genes expressed in insect cells, neutralizes the rabies virus and prevents its attachment to cells. This innovation in rabies vaccines addresses key aspects of effectiveness, accessibility, and administration, positioning companies at the forefront of the competitive landscape in the dog vaccines market.
In September 2024, Boehringer Ingelheim, a Germany-based company active in both the human and animal health sectors, acquired Saiba Animal Health AG for an undisclosed sum. This acquisition bolsters Boehringer Ingelheim's research and development capabilities in the animal health sector, with a particular emphasis on innovative therapeutic vaccines for pets that target chronic diseases like allergies, inflammation, and pain. Saiba Animal Health AG is a Switzerland-based company that specializes in providing dog vaccines.
Major companies operating in the dog vaccines market are Vetoquinol S.A., Boehringer Ingelheim GmbH, Ceva Sante Animale, Heska Corporation, Merck & Co. Inc., Virbac Animal Health Pvt. Ltd., Elanco Animal Health Incorporated, Zoetis Inc., CZ Vaccines, Indian Immunologicals Ltd., Meiji Holdings Co. Ltd., Bioveta A.S., Phibro Animal Health Corporation, Hester Biosciences Limited, High Speed Digieal Processor Architecture Pvt. Ltd., Dechra Pharmaceuticals PLC, Norbrook Inc., Biogenesis Bago SA, Vaxxinova India Private Limited, Bimeda Animal Health Ltd., Lohmann Animal Health GmbH, Biovac Ltd., Zenex Animal Health India Pvt. Ltd., Instituto Rosenbusch S A
Asia-Pacific was the largest region in the dog vaccines market in 2024. The regions covered in the dog vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the dog vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The dog vaccines market consists of sales of vaccines for dogs including core dog vaccines, and non-core dog vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Dog Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on dog vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for dog vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dog vaccines market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Attenuated Live Vaccines; Conjugate Vaccines; Inactivated Vaccines; Subunit Vaccines; Toxoid Vaccines; DNA Vaccines; Recombinant Vaccines
2) By Route Of Administration: Subcutaneous; Intramuscular; Intranasal
3) By Application: Below 6 Months; Above 6 Months
Subsegments:
1) By Attenuated Live Vaccines: Canine Parvovirus Vaccine; Canine Distemper Vaccine; Canine Adenovirus Vaccine
2) By Conjugate Vaccines: Canine Leptospira Vaccine; Canine Bordetella Vaccine
3) By Inactivated Vaccines: Canine Parvovirus Vaccine; Canine Influenza Vaccine
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Dog Vaccines Market Characteristics
3. Dog Vaccines Market Trends And Strategies
4. Dog Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Dog Vaccines Growth Analysis And Strategic Analysis Framework
5.1. Global Dog Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Dog Vaccines Market Growth Rate Analysis
5.4. Global Dog Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Dog Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Dog Vaccines Total Addressable Market (TAM)
6. Dog Vaccines Market Segmentation
6.1. Global Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
6.2. Global Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Subcutaneous
Intramuscular
Intranasal
6.3. Global Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Below 6 Months
Above 6 Months
6.4. Global Dog Vaccines Market, Sub-Segmentation Of Attenuated Live Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Canine Parvovirus Vaccine
Canine Distemper Vaccine
Canine Adenovirus Vaccine
6.5. Global Dog Vaccines Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Canine Leptospira Vaccine
Canine Bordetella Vaccine
6.6. Global Dog Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Canine Parvovirus Vaccine
Canine Influenza Vaccine
6.7. Global Dog Vaccines Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Canine Lyme Disease Vaccine
Canine Parainfluenza Vaccine
6.8. Global Dog Vaccines Market, Sub-Segmentation Of Toxoid Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Canine Leptospirosis Toxoid Vaccine
6.9. Global Dog Vaccines Market, Sub-Segmentation Of DNA Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Canine Melanoma Vaccine
6.10. Global Dog Vaccines Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Canine Lyme Disease Recombinant Vaccine
Canine Bordetella Recombinant Vaccine
7. Dog Vaccines Market Regional And Country Analysis
7.1. Global Dog Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Dog Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Dog Vaccines Market
8.1. Asia-Pacific Dog Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Dog Vaccines Market
9.1. China Dog Vaccines Market Overview
9.2. China Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Dog Vaccines Market
10.1. India Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Dog Vaccines Market
11.1. Japan Dog Vaccines Market Overview
11.2. Japan Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Dog Vaccines Market
12.1. Australia Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Dog Vaccines Market
13.1. Indonesia Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Dog Vaccines Market
14.1. South Korea Dog Vaccines Market Overview
14.2. South Korea Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Dog Vaccines Market
15.1. Western Europe Dog Vaccines Market Overview
15.2. Western Europe Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Dog Vaccines Market
16.1. UK Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Dog Vaccines Market
17.1. Germany Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Dog Vaccines Market
18.1. France Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Dog Vaccines Market
19.1. Italy Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Dog Vaccines Market
20.1. Spain Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Dog Vaccines Market
21.1. Eastern Europe Dog Vaccines Market Overview
21.2. Eastern Europe Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Dog Vaccines Market
22.1. Russia Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Dog Vaccines Market
23.1. North America Dog Vaccines Market Overview
23.2. North America Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Dog Vaccines Market
24.1. USA Dog Vaccines Market Overview
24.2. USA Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Dog Vaccines Market
25.1. Canada Dog Vaccines Market Overview
25.2. Canada Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Dog Vaccines Market
26.1. South America Dog Vaccines Market Overview
26.2. South America Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Dog Vaccines Market
27.1. Brazil Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Dog Vaccines Market
28.1. Middle East Dog Vaccines Market Overview
28.2. Middle East Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Dog Vaccines Market
29.1. Africa Dog Vaccines Market Overview
29.2. Africa Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Dog Vaccines Market Competitive Landscape And Company Profiles
30.1. Dog Vaccines Market Competitive Landscape
30.2. Dog Vaccines Market Company Profiles
30.2.1. Vetoquinol S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Heska Corporation Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Dog Vaccines Market Other Major And Innovative Companies
31.1. Virbac Animal Health Pvt. Ltd.
31.2. Elanco Animal Health Incorporated
31.3. Zoetis Inc.
31.4. CZ Vaccines
31.5. Indian Immunologicals Ltd.
31.6. Meiji Holdings Co. Ltd.
31.7. Bioveta A.S.
31.8. Phibro Animal Health Corporation
31.9. Hester Biosciences Limited
31.10. High Speed Digieal Processor Architecture Pvt. Ltd.
31.11. Dechra Pharmaceuticals PLC
31.12. Norbrook Inc.
31.13. Biogenesis Bago SA
31.14. Vaxxinova India Private Limited
31.15. Bimeda Animal Health Ltd.
32. Global Dog Vaccines Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Dog Vaccines Market
34. Recent Developments In The Dog Vaccines Market
35. Dog Vaccines Market High Potential Countries, Segments and Strategies
35.1 Dog Vaccines Market In 2029 - Countries Offering Most New Opportunities
35.2 Dog Vaccines Market In 2029 - Segments Offering Most New Opportunities
35.3 Dog Vaccines Market In 2029 - Growth Strategies
